Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy

Background: Pulmonary arterial hypertension (PAH) is described by proliferation of small pulmonary arteries leading to increased pulmonary vascular resistance, right ventricular failure, and death. Research confirms long-term improvement in composite morbidity and mortality endpoints on some endothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, George, Yeaw, Jason, Lickert, Cassandra A., De, Ajita P., Wade, Rolin L., Pruett, Janis, Drake, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2018
Materias:
Cardiovascular Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090461/
https://www.ncbi.nlm.nih.gov/pubmed/35620777
http://dx.doi.org/10.36469/9812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090461/
https://www.ncbi.nlm.nih.gov/pubmed/35620777
http://dx.doi.org/10.36469/9812

Ejemplares similares